Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN005246 | 437.2909 | 3.15 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 446.2056 | 1.2 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 481.3176 | 3.63 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 523.364 | 3.52 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 567.5542 | 11.8 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 674.5361 | 6.07 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 688.5515 | 6.71 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 695.6773 | 12.81 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 702.5685 | 7.46 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 704.583 | 8.14 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 718.4801 | 5.52 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 731.5468 | 7.97 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 759.5824 | 11.93 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 773.5932 | 11.94 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 773.627 | 11.9 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 776.5599 | 9.59 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 779.5901 | 11.82 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 781.5763 | 11.69 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 783.5403 | 11.42 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 787.5355 | 7.74 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 789.5495 | 9.54 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 799.6051 | 11.94 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 801.6195 | 12.21 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 805.553 | 7.51 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 806.4948 | 5.36 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 808.5103 | 6.14 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 811.533 | 9.51 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 811.5407 | 7.79 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 814.6842 | 12.18 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 821.5178 | 8.33 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 834.5259 | 6.26 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 834.5263 | 6.41 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 836.5417 | 7.46 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 836.5418 | 7.45 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 837.5533 | 8.03 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 843.5978 | 11.56 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 858.5254 | 6.3 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 860.541 | 6.59 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 860.5417 | 6.79 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 862.5577 | 7.86 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 864.5729 | 9.24 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 869.6122 | 8.93 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 872.5414 | 6.92 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 875.5631 | 11.47 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 877.5802 | 11.68 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 882.5245 | 6.1 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 882.5248 | 5.79 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 884.5405 | 6.78 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 884.5414 | 6.43 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 886.5571 | 7.33 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 886.5572 | 7.33 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 886.5577 | 7.66 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 888.5733 | 8.39 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 890.5856 | 9.71 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 893.6116 | 8.41 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 898.5598 | 7.05 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 910.5561 | 7.37 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 910.5563 | 6.55 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 912.5694 | 7.81 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells | |
| AN005246 | 914.5883 | 9.03 | Minutes | ST003196 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Leukemia cells |
